The size of the Europe Tangential Flow filtration Market is valued at USD 100.35 Million in 2020. It is estimated to grow at a CAGR of 10.5%, to reach USD 165.32 million by 2025.
Increasing enhancements among pharmaceutical companies are majorly impelling the market growth in Europe. Growing expenses for the R & D by the biotechnology and pharmaceutical companies and an increase in biologics and CMOs are further escalating the market demand. The growing adoption of single-use technologies in the pharmaceutical industry is prompting market growth. An extensive range of applications in the field of biologics is boosting market demand. The rise in technological advancements, leading to well-established healthcare infrastructure, and the existence of intellectual property system for new biological production are driving the TFF market growth.
Strict rules by the government to approve new technologies are projected to hamper the market growth. The vast amount required to set up the novel production services is another factor restraining the market demand.
This research report on the Europe Tangential Flow Filtration Market has been segmented and sub-segmented into the following categories:
By Product:
By Membrane Material:
By Technology:
By pore size:
By Application:
By Country:
Based on region, Europe had the least CAGR during the forecast period. The reasons for the same might be government policies. The United Kingdom is leading the market with the highest share. The massive existence of key players and pharmaceutical companies are influencing the market growth. Growing government funds and investments to launch new products boost the development of the tangential flow filtration market. Germany is next to the UK is leading the TFF market. Rising disposable income in urban areas is greatly enhancing the demand of the market in this country.
Prominent Companies leading the Europe Tangential Flow Filtration Market Profiled in the Report are GE Healthcare, Merck Millipore, Danaher Corporation, Sartorius Stedim Biotech S.A, Parker Hannifin Corporation.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Product
5.1.1 Single Use Systems
5.1.2 Reusable Systems
5.1.3 Membrane Filters
5.1.3.1 Casettes
5.1.3.2 Cartridges
5.1.4 Filtration Accessories
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Membrane Material
5.2.1 Polyethersulfone
5.2.2 Regenerated Cellulose
5.2.3 Other Materials
5.2.4 Y-o-Y Growth Analysis, By Membrane Material
5.2.5 Market Attractiveness Analysis, By Membrane Material
5.2.6 Market Share Analysis, By Membrane Material
5.3 Technology
5.3.1 Ultrafiltration
5.3.2 Microfiltration
5.3.3 Reverse Osmosis
5.3.4 Y-o-Y Growth Analysis, By Technology
5.3.5 Market Attractiveness Analysis, By Technology
5.3.6 Market Share Analysis, By Technology
5.4 Pore Size/MWCO
5.4.1 Ultrafilters
5.4.2 Microfilters
5.4.3 Reverse Osmosis Filters
5.4.4 Y-o-Y Growth Analysis, By Pore Size/MWCO
5.4.5 Market Attractiveness Analysis, By Pore Size/MWCO
5.4.6 Market Share Analysis, By Pore Size/MWCO
5.5 Application
5.5.1 Bioprocessing
5.5.2 Product Concentration
5.5.3 Purification & Diafiltration
5.5.4 Viral Vectors and Vaccine Purification
5.5.5 Pharmaceutical Water Production
5.5.6 Other Applications
5.5.7 Y-o-Y Growth Analysis, ByApplication
5.5.8 Market Attractiveness Analysis, By Application
5.5.9 Market Share Analysis, By Application
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Membrane Material
6.1.3.4 By Technology
6.1.3.5 By Pore Size
6.1.3.6 By Application
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Membrane Material
6.1.4.4 By Technology
6.1.4.5 By Pore Size
6.1.4.6 By Application
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Membrane Material
6.1.5.4 By Technology
6.1.5.5 By Pore Size
6.1.5.6 By Application
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 GE Healthcare (U.S.).
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Merck Millipore (U.S.)
8.3 Danaher Corporation (U.S.)
8.4 Sartorius Stedim Biotech S.A. (France)
8.5 Parker Hannifin Corporation (U.S.)
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, Collaborations, and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
